Secondary prevention of stroke by a primary health care approach: An open-label cluster randomised trial

被引:7
|
作者
Sylaja, P. N. [1 ]
Singh, Gurpreet [2 ]
Sivasambath, S. [1 ]
Arun, K. [1 ]
Jeemon, Panniyammakal [2 ]
Antony, Roni [1 ]
Kalani, Rizwan [3 ]
Gopal, Bipin K. [4 ]
Soman, Biju [2 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Comprehens Stroke Care Program, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol, Achuta Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India
[3] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
[4] Govt Kerala, Dept Hlth Serv, Thiruvananthapuram, Kerala, India
关键词
Stroke; Secondary prevention; Task shifting; Primary care; Health worker; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; PREVALENCE; COUNTRIES; SERVICES; BURDEN; INDIA;
D O I
10.1016/j.jocn.2020.12.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and aim: Increasing stroke burden in developing countries necessitates measures to strengthen health systems. We aimed to evaluate whether a Community Health Worker (CHW) based educational intervention will improve risk factor control among stroke survivors and enhance behavior change communication. Method: An open-label, cluster-randomized trial was conducted in rural area of Thiruvananthapuram district, Kerala from December 2017 to December 2018. A CHW-based educational intervention in addition to standard of care was provided in intervention arm and compared to standard clinical care in the control arm with follow-up at three and six months. The primary outcome measures were risk factor control and quality of behavior change communication provided by CHWs. Results: Of the 234 Stroke/TIA survivors enrolled, the mean age (SD) was 59.43 (11.07) years. At 6-month follow up, all patients with smokeless tobacco consumption had quit in the intervention arm (5 at baseline and 0 at six months) and no relapse in smoking was found (as compared to control arm wherein 9 at baseline and one at 6 months). The control of hypertension and diabetes was not significant at 3 months and 6 months in both intervention and control groups. Home visits as well as health education on risk factors by CHWs in the intervention arm were significantly higher. Conclusion: Community health worker-based intervention is feasible in resource constrained settings for secondary stroke prevention. Training of CHW on risk factor control and lifestyle modifications for stroke survivors enhances quality of health education provided by health services. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [31] FLUID trial: a protocol for a hospital-wide open-label cluster crossover pragmatic comparative effectiveness randomised pilot trial
    McIntyre, Lauralyn
    Taljaard, Monica
    McArdle, Tracy
    Fox-Robichaud, Alison
    English, Shane W.
    Martin, Claudio
    Marshall, John
    Menon, Kusum
    Muscedere, John
    Cook, Deborah J.
    Weijer, Charles
    Saginur, Raphael
    Maybee, Alies
    Iyengar, Akshai
    Forster, Alan
    Graham, Ian D.
    Hawken, Steven
    McCartney, Colin
    Seely, Andrew Je
    Stiell, Ian G.
    Thavorn, Kednapa
    Fergusson, Dean A.
    BMJ OPEN, 2018, 8 (08):
  • [32] Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
    Roddy, Edward
    Clarkson, Kris
    Blagojevic-Bucknall, Milica
    Mehta, Rajnikant
    Oppong, Raymond
    Avery, Anthony
    Hay, Elaine M.
    Heneghan, Carl
    Hartshorne, Liz
    Hooper, Julie
    Hughes, Gemma
    Jowett, Sue
    Lewis, Martyn
    Little, Paul
    McCartney, Karen
    Mahtani, Kamal R.
    Nunan, David
    Santer, Miriam
    Williams, Sam
    Mallen, Christian D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (02) : 276 - 284
  • [33] Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
    Parperis, Konstantinos
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (12) : E202 - E202
  • [34] Early Prolonged Ambulatory Cardiac monitoring in Stroke (EPACS): an open-label randomised controlled trial and economic evaluation
    Kaura, A.
    Sztriha, L.
    Chan, F. K.
    Aeron-Thomas, J.
    Gall, N.
    Piechowski-Jozwiak, B.
    Teo, J. T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4138 - 4138
  • [35] Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial
    Khunti, Kamlesh
    Stone, Margaret
    Paul, Sanjoy
    Baines, Jan
    Gisborne, Louise
    Farooqi, Azhar
    Luan, Xiujie
    Squire, Iain
    HEART, 2007, 93 (11) : 1398 - 1405
  • [36] Re: The Preventive Antibiotics in Stroke Study (PASS): A Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial
    Schaeffer, Edward M.
    JOURNAL OF UROLOGY, 2016, 195 (02): : 369 - 369
  • [37] Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
    Naslund, Ulf
    Ng, Nawi
    Lundgren, Anna
    Fharm, Eva
    Gronlund, Christer
    Johansson, Helene
    Lindahl, Bernt
    Lindahl, Bertil
    Lindvall, Kristina
    Nilsson, Stefan K.
    Nordin, Maria
    Nordin, Steven
    Nyman, Emma
    Rocklov, Joacim
    Vanoli, Davide
    Weinehall, Lars
    Wennberg, Patrik
    Wester, Per
    Norberg, Margareta
    LANCET, 2019, 393 (10167): : 133 - 142
  • [38] Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial
    Ishihara, Masaharu
    Asakura, Masanori
    Hibi, Kiyoshi
    Okada, Kozo
    Shimizu, Wataru
    Takano, Hitoshi
    Suwa, Satoru
    Fujii, Kenshi
    Okumura, Yasuo
    Mano, Toshiaki
    Tsujita, Kenichi
    Igeta, Masataka
    Okamoto, Rika
    Suna, Shinichiro
    EUROINTERVENTION, 2022, 18 (08) : E647 - E655
  • [39] Impact of a community health worker led intervention for improved blood pressure control in urban Nepal: an open-label cluster randomised controlled trial
    Bhattarai, Sanju
    Skovlund, Eva
    Shrestha, Archana
    Mjolstad, Bente Prytz
    Asvold, Bjorn Olav
    Sen, Abhijit
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 29
  • [40] Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial
    Bailly, Pierre
    Egreteau, Pierre-Yves
    Ehrmann, Stephan
    Thille, Arnaud W.
    Guitton, Christophe
    Grillet, Guillaume
    Reizine, Florian
    Huet, Olivier
    Jaber, S.
    Nowak, Emmanuel
    L'her, Erwan
    BMJ OPEN, 2021, 11 (02):